It acts by blocking the activities of the serine-threnoine kinases Raf-1 and B-Raf, and the receptor tyrosine kinases of the vascular endothelial growth factor receptors [5]–[7], consequently inhibiting tumor-cell proliferation and tumor angiogenesis [5], [6], [8]. Here, BRAF is linked to neoplasm.